Neogenomics Inc (NASDAQ:NEO)

9.60
Delayed Data
As of Apr 26
 +0.14 / +1.48%
Today’s Change
7.08
Today|||52-Week Range
11.63
+8.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues61.7M66.1M63.1M67.8M
 
 
 
 
 
Cost of Goods Sold30.5M31.0M30.4M30.8M
 
 
 
 
 
Depreciation And Amortization5.7M5.6M5.5M5.7M
 
 
 
 
 
 
Operating ExpensesGross Income25.5M29.5M27.1M31.3M
 
 
 
 
 
General Expenses25.6M28.2M29.4M26.9M
 
 
 
 
 
Research And Development862.0K947.0K1.3M556.0K
 
 
 
 
 
Total Operating Expenses61.8M64.8M65.4M63.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-115.0K1.3M-2.3M4.5M
 
 
 
 
 
Interest Expense On Debt1.4M1.4M1.4M1.4M
 
 
 
 
 
Other Expenses0.000.00-1.1M-264.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.5M-97.0K-4.8M2.9M
 
 
 
 
 
Income Taxes-825.0K-54.0K-340.0K-2.1M
 
 
 
 
 
Preferred Dividend-2.6M-2.6M-2.7M-2.7M
 
 
 
 
 
Net Income-654.0K-43.0K-5.1M5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.7M79.4M79.6M86.7M
 
 
 
 
 
Shares To Calculate EPS Diluted78.7M79.4M79.6M88.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.03-$0.10$0.03
 
 
 
 
 
EPS Diluted-$0.04-$0.03-$0.10$0.03